Hunan Er-Kang Pharmaceutical Co Ltd

300267

Company Profile

  • Business description

    Hunan Er-Kang Pharmaceutical Co Ltd develops, produces and sells pharmaceutical products in China. The company's main products include pharmaceutical excipients and antibiotics. It offers pharmaceutical excipients, APIs and finished drug products. The pharmaceutical excipients include products such as glycerol, ethanol pharmaceutically, acceptable propylene glycol, sodium hydroxide, and pharmaceutically acceptable sugar. The company's finished drugs primarily include sulbenicillin sodium for injection and compound liquorice tablets. Its APIs include glycerin, dilute hydrochloric acid, dihydroxypropyl theophylline, sulbenicillin sodium, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. Geographically, all the activities are carried out through China.

  • Contact

    Kangping Road 167
    National Economic and Technological Development Zone
    Liuyang Changsha
    Hunan410331
    CHN

    T: +86 73184659108

    http://www.hnerkang.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    1,453

Stocks News & Analysis

stocks

Record production for Woodside

Our fair value is updated as progress is made on new development projects.
stocks

Meta earnings: Strong end to 2025 as AI monetization begins to show

Investors please with latest results.
stocks

Why doesn’t the market like the earnings from this US tech giant?

Good quarter with AI demand ramping.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,164.8094.40-1.02%
CAC 408,126.5355.170.68%
DAX 4024,538.81229.350.94%
Dow JONES (US)48,892.47179.09-0.36%
FTSE 10010,223.5451.780.51%
HKSE27,387.11580.98-2.08%
NASDAQ23,461.82223.30-0.94%
Nikkei 22553,322.8552.75-0.10%
NZX 50 Index13,423.1874.570.56%
S&P 5006,939.0329.98-0.43%
S&P/ASX 2008,869.1086.00-0.96%
SSE Composite Index4,117.9540.04-0.96%

Market Movers